Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CINELINE.NS Stock Summary
Top 10 Correlated ETFs
CINELINE.NS
In the News
CINELINE.NS Financial details
Company Rating
Buy
Market Cap
2.92B
Income
12.48M
Revenue
1.1B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
43
Optionable
No
Shortable
Yes
Earnings
07 Feb 2023
P/E
234.34
Forward P/E
-
PEG
-27.92
P/S
2.65
P/B
1.94
P/C
-
P/FCF
-
Quick Ratio
0.69
Current Ratio
1.24
Debt / Equity
-
LT Debt / Equity
2.07
-
-
EPS (TTM)
0.27
EPS next Y
-
EPS next Q
-
EPS this Y
-840.69%
EPS next Y
-
EPS next 5Y
1068.7%
EPS last 5Y
NAN%
Revenue last 5Y
15.12%
Revenue Q/Q
74.36%
EPS Q/Q
-127.93%
-
-
-
-
SMA20
-5.35%
SMA50
-9.23%
SMA100
-9.49%
Inst Own
-
Inst Trans
-
ROA
-
ROE
1%
ROC
0.01%
Gross Margin
77%
Oper. Margin
4%
Profit Margin
1%
Payout
-
Shs Outstand
31.57M
Shs Float
10.43M
-
-
-
-
Target Price
-
52W Range
91.1-175.0
52W High
-45.31%
52W Low
+5.16%
RSI
37.37
Rel Volume
0.07
Avg Volume
41.45K
Volume
2.85K
Perf Week
-5.62%
Perf Month
-10.14%
Perf Quarter
-18.93%
Perf Half Y
-16.96%
-
-
-
-
Beta
0.725563
-
-
Volatility
3%, 3.65%
Prev Close
3.57%
Price
95.7
Change
-0.31%
CINELINE.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 7.95 | 8.65 | 9.16 | 10.2 | 16.07 | |
Net income per share | 3.77 | 3.52 | 2.73 | 1.71 | -12.67 | |
Operating cash flow per share | 27.41 | -0.82 | 7.6 | -0.74 | 3.53 | |
Free cash flow per share | -1.32 | -3.96 | 7.6 | -0.74 | 3.53 | |
Cash per share | 0.41 | 7.92 | 2.84 | 8.83 | 10.73 | |
Book value per share | 37.32 | 40.84 | 43.56 | 45.28 | 38.92 | |
Tangible book value per share | 37.32 | 40.84 | 43.56 | 45.22 | 17.79 | |
Share holders equity per share | 37.32 | 40.84 | 43.56 | 45.28 | 38.92 | |
Interest debt per share | 48.83 | 59.5 | 68.15 | 122.83 | 127.63 | |
Market cap | 2.02B | 1.28B | 525M | 879.2M | 2.8B | |
Enterprise value | 3.3B | 2.64B | 2.25B | 4.07B | 5.74B | |
P/E ratio | 19.15 | 13.02 | 6.88 | 18.37 | -7.89 | |
Price to sales ratio | 9.08 | 5.29 | 2.05 | 3.08 | 6.22 | |
POCF ratio | 2.63 | -56.16 | 2.47 | -42.67 | 28.29 | |
PFCF ratio | -54.6 | -11.57 | 2.47 | -42.67 | 28.29 | |
P/B Ratio | 1.93 | 1.12 | 0.43 | 0.69 | 2.57 | |
PTB ratio | 1.93 | 1.12 | 0.43 | 0.69 | 2.57 | |
EV to sales | 14.82 | 10.9 | 8.75 | 14.23 | 12.76 | |
Enterprise value over EBITDA | 13.46 | 10.22 | 6.74 | 10.84 | 42.47 | |
EV to operating cash flow | 4.3 | -115.62 | 10.55 | -197.34 | 58.05 | |
EV to free cash flow | -89.18 | -23.82 | 10.55 | -197.34 | 58.05 | |
Earnings yield | 0.05 | 0.08 | 0.15 | 0.05 | -0.13 | |
Free cash flow yield | -0.02 | -0.09 | 0.41 | -0.02 | 0.04 | |
Debt to equity | 1.37 | 1.52 | 1.67 | 2.74 | 3.14 | |
Debt to assets | 0.58 | 0.6 | 0.62 | 0.73 | 0.76 | |
Net debt to EBITDA | 5.22 | 5.25 | 5.17 | 8.49 | 21.78 | |
Current ratio | 0.68 | 9.45 | 1.26 | 1.69 | 1.55 | |
Interest coverage | 1.45 | 1.5 | 0.63 | 0.25 | -0.23 | |
Income quality | 7.27 | -0.23 | 2.79 | -0.43 | -0.28 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.16 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.03 | 0.02 | 0.05 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.13 | |
Capex to operating cash flow | -1.05 | 3.85 | 0 | 0 | 0 | |
Capex to revenue | -3.61 | -0.36 | 0 | 0 | 0 | |
Capex to depreciation | -22.47 | -2.42 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 56.25 | 56.85 | 51.69 | 41.73 | 105.32 | |
ROIC | 0.04 | 0.04 | 0.03 | 0.01 | -0.02 | |
Return on tangible assets | 0.04 | 0.03 | 0.02 | 0.01 | -0.09 | |
Graham Net | -50.65 | -54.18 | -69.73 | -115.24 | -111.46 | |
Working capital | -30.5M | 477.28M | 54.5M | 152.4M | 180.56M | |
Tangible asset value | 1.05B | 1.14B | 1.22B | 1.27B | 498.02M | |
Net current asset value | -1.37B | -1.2B | -1.77B | -3.1B | -2.92B | |
Invested capital | 1.24 | 1.38 | 1.41 | 2.54 | 2.96 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 6.34M | 4.51M | 5.83M | 36.38M | 65.44M | |
Average inventory | 0 | 0 | 0 | 876K | 2.11M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 60.56 | 14.71 | 69.58 | 272.38 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 7.6 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 6.03 | 24.81 | 5.25 | 1.34 | 0 | |
Inventory turnover | 0 | 0 | 0 | 48.04 | 0 | |
ROE | 0.1 | 0.09 | 0.06 | 0.04 | -0.33 | |
Capex per share | -28.73 | -3.14 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 6.3 | 4.8 | 9.71 | 7.59 | 13.2 | |
Net income per share | -1.07 | -2.43 | -1.17 | 5.37 | -1.5 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 9.94 | 0 | 12 | 0 | |
Book value per share | 0 | 36.05 | 0 | 47.68 | 0 | |
Tangible book value per share | 0 | 16.48 | 0 | 28.77 | 0 | |
Share holders equity per share | 0 | 36.05 | 0 | 47.68 | 0 | |
Interest debt per share | 0 | 109.23 | 0 | 107.79 | 0 | |
Market cap | 2.88B | 3.02B | 4.14B | 3.69B | 3.42B | |
Enterprise value | 0 | 5.97B | 0 | 6.72B | 0 | |
P/E ratio | -22.29 | -10.3 | -28.59 | 5.44 | -18.01 | |
Price to sales ratio | 15.15 | 20.82 | 13.78 | 15.39 | 8.19 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 2.77 | 0 | 2.45 | 0 | |
PTB ratio | 0 | 2.77 | 0 | 2.45 | 0 | |
EV to sales | 0 | 41.12 | 0 | 28.02 | 0 | |
Enterprise value over EBITDA | 0 | 92.69 | 0 | 22.25 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.01 | -0.02 | -0.01 | 0.05 | -0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 3.14 | 0 | 2.45 | 0 | |
Debt to assets | 0 | 0.76 | 0 | 0.71 | 0 | |
Net debt to EBITDA | 0 | 45.75 | 0 | 10.02 | 0 | |
Current ratio | 0 | 1.55 | 0 | 1.24 | 0 | |
Interest coverage | 0.39 | 0.24 | 0.64 | -0.39 | 0.24 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.13 | 0 | 0.11 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 44.36 | 0 | 75.9 | 0 | |
ROIC | 0 | 0.01 | 0 | -0.01 | 0 | |
Return on tangible assets | 0 | -0.02 | 0 | 0.04 | 0 | |
Graham Net | 0 | -103.24 | 0 | -104.69 | 0 | |
Working capital | 0 | 180.56M | 0 | 131.39M | 0 | |
Tangible asset value | 0 | 498.02M | 0 | 908.29M | 0 | |
Net current asset value | 0 | -2.92B | 0 | -3.01B | 0 | |
Invested capital | 0 | 2.96 | 0 | 2.21 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 586.59 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 41.02 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0.15 | 0 | |
Inventory turnover | 0 | 0 | 0 | 2.19 | 0 | |
ROE | 0 | -0.07 | 0 | 0.11 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CINELINE.NS Frequently Asked Questions
What is Cineline India Limited stock symbol ?
Cineline India Limited is a IN stock and trading under the symbol CINELINE.NS
What is Cineline India Limited stock quote today ?
Cineline India Limited stock price is $95.7 today.
Is Cineline India Limited stock public?
Yes, Cineline India Limited is a publicly traded company.